Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Therapeutics and Clinical Risk Management|February 12, 2009
Effectiveness of twice daily azelastine nasal spray in patients with seasonal allergic rhinitisFriedrich Horak
Expert Opinion on Investigational Drugs|May 10, 2011
VTX-1463, a novel TLR8 agonist for the treatment of allergic rhinitisFriedrich Horak
Expert Review of Clinical Immunology|May 19, 2010
Azelastine nasal spray for the treatment of allergic and nonallergic rhinitisFriedrich Horak, Ursula Petra Zieglmayer
International Archives of Allergy and Immunology|December 8, 2004
Transition from a botanical to a molecular classification in tree pollen allergy: implications for diagnosis and therapyNadine Mothes, Friedrich Horak, Rudolf Valenta
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|November 28, 2009
The effects of bilastine compared with cetirizine, fexofenadine, and placebo on allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna Challenge ChamberFriedrich Horak, Petra Zieglmayer, René Zieglmayer, et al.
Current Topics in Microbiology and Immunology|May 13, 2011
Clinical experience with recombinant molecules for allergy vaccinationOliver Cromwell, Verena Niederberger, Friedrich Horak, et al.
Arzneimittel-Forschung|June 11, 2010
Onset of action of loratadine/montelukast in seasonal allergic rhinitis patients exposed to grass pollenFriedrich Horak, Petra Zieglmayer, René Zieglmayer, et al.
Expert Review of Clinical Immunology|September 11, 2014
Five-grass-pollen sublingual immunotherapy tablet for the treatment of grass-pollen-induced allergic rhinoconjunctivitis: 5 years of experienceAlain Didier, Ulrich Wahn, Friedrich Horak, et al.
The Journal of Allergy and Clinical Immunology|June 14, 2002
Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unitFriedrich Horak, Ursula P Stübner, Rene Zieglmayer, et al.
British Journal of Clinical Pharmacology|June 21, 2005
Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administrationFriedrich Horak, Petra U Zieglmayer, R Zieglmayer, et al.
Pageof 6